Skip to main content

Development of peptide antagonists for the androgen receptor using combinatorial peptide phage display.

Publication ,  Journal Article
Chang, C-Y; Abdo, J; Hartney, T; McDonnell, DP
Published in: Mol Endocrinol
October 2005

Under the auspices of the Nuclear Receptor Signaling Atlas (NURSA), we have undertaken to evaluate the feasibility of targeting nuclear receptor-coactivator surfaces for new drug discovery. The underlying objective of this approach is to provide the research community with reagents that can be used to modulate the transcriptional activity of nuclear receptors. Using combinatorial peptide phage display, we have been able to develop peptide antagonists that target specific nuclear receptor (NR)-coactivator binding surfaces. It can be appreciated that reagents of this nature will be of use in the study of orphan nuclear receptors for whom classical ligands have not yet been identified. In addition, because the interaction of coactivators with the receptor is an obligate step for NR transcriptional activity, it is anticipated that peptides that block these interactions will enable the definition of the biological and pharmacological significance of individual NR-coactivator interactions. In this report, we describe the use of this approach to develop antagonists of the androgen receptor by targeting its coactivator-binding pocket and their use to study the coactivator-binding surface of this receptor. Based on our findings, we believe that molecules that function by disrupting the androgen receptor-cofactor interactions will have use in the treatment of prostate cancer.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Mol Endocrinol

DOI

ISSN

0888-8809

Publication Date

October 2005

Volume

19

Issue

10

Start / End Page

2478 / 2490

Location

United States

Related Subject Headings

  • Two-Hybrid System Techniques
  • Transcriptional Activation
  • Recombinant Proteins
  • Receptors, Androgen
  • Protein Binding
  • Peptides
  • Peptide Library
  • Molecular Sequence Data
  • In Vitro Techniques
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chang, C.-Y., Abdo, J., Hartney, T., & McDonnell, D. P. (2005). Development of peptide antagonists for the androgen receptor using combinatorial peptide phage display. Mol Endocrinol, 19(10), 2478–2490. https://doi.org/10.1210/me.2005-0072
Chang, Ching-Yi, Jennifer Abdo, Tanya Hartney, and Donald P. McDonnell. “Development of peptide antagonists for the androgen receptor using combinatorial peptide phage display.Mol Endocrinol 19, no. 10 (October 2005): 2478–90. https://doi.org/10.1210/me.2005-0072.
Chang C-Y, Abdo J, Hartney T, McDonnell DP. Development of peptide antagonists for the androgen receptor using combinatorial peptide phage display. Mol Endocrinol. 2005 Oct;19(10):2478–90.
Chang, Ching-Yi, et al. “Development of peptide antagonists for the androgen receptor using combinatorial peptide phage display.Mol Endocrinol, vol. 19, no. 10, Oct. 2005, pp. 2478–90. Pubmed, doi:10.1210/me.2005-0072.
Chang C-Y, Abdo J, Hartney T, McDonnell DP. Development of peptide antagonists for the androgen receptor using combinatorial peptide phage display. Mol Endocrinol. 2005 Oct;19(10):2478–2490.

Published In

Mol Endocrinol

DOI

ISSN

0888-8809

Publication Date

October 2005

Volume

19

Issue

10

Start / End Page

2478 / 2490

Location

United States

Related Subject Headings

  • Two-Hybrid System Techniques
  • Transcriptional Activation
  • Recombinant Proteins
  • Receptors, Androgen
  • Protein Binding
  • Peptides
  • Peptide Library
  • Molecular Sequence Data
  • In Vitro Techniques
  • Humans